Jazz triggers Codiak’s first exosome alliance with a $76M ante and up to $1B-plus in milestones
Codiak CEO Doug Williams has notched his first collaboration deal.
The biotech exec and his team are collecting a $56 million upfront from Jazz Pharmaceuticals …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
